InvestorsHub Logo
Followers 33
Posts 5264
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Tuesday, 02/28/2023 8:06:38 AM

Tuesday, February 28, 2023 8:06:38 AM

Post# of 424193
BRIEF-Amarin And Csl Seqirus Announce Exclusive License And Distribution Agreement To Commercialize Vazkepa In Australia And New Zealand
REUTERS 8:05 AM ET 2/28/2023
Symbol Last Price Change
AMRN 1.84up 0 (0%)
QUOTES AS OF 04:00:00 PM ET 02/27/2023
Feb 28 (Reuters) - Amarin Corporation PLC(AMRN):

* AMARIN AND CSL SEQIRUS ANNOUNCE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT TO COMMERCIALIZE VAZKEPA (ICOSAPENT ETHYL) IN AUSTRALIA AND NEW ZEALAND

* UNDER TERMS OF AGREEMENT, CSL SEQIRUS WILL IN-LICENSE VAZKEPA FROM AMARIN

* CSL SEQIRUS TO BE RESPONSIBLE FOR MARKET ACCESS, REIMBURSEMENT EFFORTS, DISTRIBUTION, FOR VAZKEPA ACROSS AUSTRALIA, NEW ZEALAND

* AMARIN WILL RECEIVE AN UPFRONT PAYMENT AND BE ELIGIBLE FOR EVENT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $8 MILLION

* AMARIN WILL RECEIVE ADDITIONAL PRODUCT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $4 MILLION Source text for Eikon: Further company coverage:

(c) Copyright Thomson Reuters 2023. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News